Suppression of pain and inflammation still continues to be a challenge despite the availability of a number of non-steroidal anti-inflammatory drugs (NSAIDs). This is because NSAIDs do not only exhibit a different spectrum of analgesic, anti-pyretic and anti-inflammatory effects but also cause gastrointestinal (GI) complications ranging from dyspepsia to fatal upper GI tract bleeding and perforation (1). Efforts to improve the adverse effect profile of the current NSAIDs have been focused on developing prodrugs (2) or modifications of marketed formulations (3). These approaches have been only partially successful. A recent approach is development of selective cyclooxygenase (COX)-2 inhibitors (4-6). COX is the key enzyme that catalyzes the conversion of arachidonic acid to prostaglandins and thromboxans. There are two types of cyclooxygenase enzymes, COX-1 and COX-2. Currently available NSAIDs inhibit both COX-1 and COX-2 enzymes. Inhibition of COX-1 reduces basal production of cytoprotective prostaglandins (PGs) PGE2 and PGI2 and hence causes ulceration while inhibition of COX-2 inhibits inflammation. Complete inhibition of COX-1 is therefore not preferred and drugs that inhibit the COX-2 enzyme are better anti-inflammatory agents (7,8).Owing to the continuous efforts in exploring the structural insights to aid the design (9, 10) and synthesis of safer novel anti-inflammatory agents, 2-amino-5-sulfanyl--1,3,4-thiadiazole was identified as the central nucleus. To date, 2-amino-5-sulfanyl--1,3,4-thiadiazole derivatives have not been reported to exhibit anti-inflammatory and A new series of cyclooxygenase-2 inhibitors with 2-amino--5-sulfanyl-1,3,4-thiadiazole as the central scaffold unit has been synthesized. The newly synthesized compounds were characterized by analytical and spectral methods. Compounds were screened for cyclooxygenase inhibitory activity by the colorimetric COX (ovine) inhibitor screening assay, anti-inflammatory activity by the carrageenean induced rat paw oedema test and analgesic activity by the tail flick method. Some compounds exhibited significant biological activity.